Cargando…

MIEF2 over-expression promotes tumor growth and metastasis through reprogramming of glucose metabolism in ovarian cancer

BACKGROUND: Increasing evidence has revealed the close link between mitochondrial dynamic dysfunction and cancer. MIEF2 (mitochondrial elongation factor 2) is mitochondrial outer membrane protein that functions in the regulation of mitochondrial fission. However, the expression, clinical significanc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Shuhua, Zhang, Xiaohong, Shi, Yuan, Cheng, Lu, Song, Tingting, Wu, Bing, Li, Jia, Yang, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737286/ https://www.ncbi.nlm.nih.gov/pubmed/33317572 http://dx.doi.org/10.1186/s13046-020-01802-9

Ejemplares similares

MIEF2 reprograms lipid metabolism to drive progression of ovarian cancer through ROS/AKT/mTOR signaling pathway
por: Zhao, Shuhua, et al.
Publicado: (2021)

CPT2 down-regulation promotes tumor growth and metastasis through inducing ROS/NFκB pathway in ovarian cancer
por: Zhang, Xiaohong, et al.
Publicado: (2021)

PYGL-mediated glucose metabolism reprogramming promotes EMT phenotype and metastasis of pancreatic cancer
por: Ji, Qian, et al.
Publicado: (2023)

MIEF1/2 orchestrate mitochondrial dynamics through direct engagement with both the fission and fusion machineries
por: Yu, Rong, et al.
Publicado: (2021)

Adrenomedullin induces cisplatin chemoresistance in ovarian cancer through reprogramming of glucose metabolism
por: Dou, Lei, et al.
Publicado: (2023)

Human MIEF1 recruits Drp1 to mitochondrial outer membranes and promotes mitochondrial fusion rather than fission
por: Zhao, Jian, et al.
Publicado: (2011)

Circular RNA KIF4A Promotes Liver Metastasis of Breast Cancer by Reprogramming Glucose Metabolism
por: Huang, Jun, et al.
Publicado: (2022)

Breast cancer-secreted miR-122 reprograms glucose metabolism in pre-metastatic niche to promote metastasis
por: Fong, Miranda Y., et al.
Publicado: (2015)

Rac1 promotes the reprogramming of glucose metabolism and the growth of colon cancer cells through upregulating SOX9
por: Liang, Jiaxin, et al.
Publicado: (2022)

Succinate dehydrogenase 5 regulates lung cancer metastasis by reprogramming glucose metabolism
por: Li, Jie, et al.
Publicado: (2021)

MIEF1/2 function as adaptors to recruit Drp1 to mitochondria and regulate the association of Drp1 with Mff
por: Yu, Rong, et al.
Publicado: (2017)

Dominant mutations in MIEF1 affect mitochondrial dynamics and cause a singular late onset optic neuropathy
por: Charif, Majida, et al.
Publicado: (2021)

Heterocellular OSM-OSMR signalling reprograms fibroblasts to promote pancreatic cancer growth and metastasis
por: Lee, Brian Y., et al.
Publicado: (2021)

TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1α degradation
por: Chen, Yongchang, et al.
Publicado: (2022)

MIG‐6 is essential for promoting glucose metabolic reprogramming and tumor growth in triple‐negative breast cancer
por: He, Jiabei, et al.
Publicado: (2021)

Glucose metabolism reprogramming promotes immune escape of hepatocellular carcinoma cells
por: Zhang, Qiuyue, et al.
Publicado: (2023)

The Molecular Assembly State of Drp1 Controls its Association With the Mitochondrial Recruitment Receptors Mff and MIEF1/2
por: Yu, Rong, et al.
Publicado: (2021)

Proteomic and Phosphoproteomic Reprogramming in Epithelial Ovarian Cancer Metastasis
por: Frederick, Mallory I., et al.
Publicado: (2023)

The Role of Reprogrammed Glucose Metabolism in Cancer
por: Ediriweera, Meran Keshawa, et al.
Publicado: (2023)

Glucose metabolic reprogramming in autoimmune diseases
por: Jeong, Hoim, et al.
Publicado: (2023)

MFN1-dependent alteration of mitochondrial dynamics drives hepatocellular carcinoma metastasis by glucose metabolic reprogramming
por: Zhang, Ze, et al.
Publicado: (2019)

Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects
por: Shang, Run-Ze, et al.
Publicado: (2016)

CRISPR-based knockout screening identifies the loss of MIEF2 to enhance oxaliplatin resistance in colorectal cancer through inhibiting the mitochondrial apoptosis pathway
por: Xie, Chaozheng, et al.
Publicado: (2022)

Mst1 overexpression combined with Yap knockdown augments thyroid carcinoma apoptosis via promoting MIEF1-related mitochondrial fission and activating the JNK pathway
por: Zhang, Xiaoli, et al.
Publicado: (2019)

PTP4A1 promotes oral squamous cell carcinoma (OSCC) metastasis through altered mitochondrial metabolic reprogramming
por: Liu, Bing, et al.
Publicado: (2023)

Leukemia inhibitory factor drives glucose metabolic reprogramming to promote breast tumorigenesis
por: Yue, Xuetian, et al.
Publicado: (2022)

Cholesterol reprograms glucose and lipid metabolism to promote proliferation in colon cancer cells
por: Mayengbam, Shyamananda Singh, et al.
Publicado: (2023)

FOXM1 promotes reprogramming of glucose metabolism in epithelial ovarian cancer cells via activation of GLUT1 and HK2 transcription
por: Wang, Yu, et al.
Publicado: (2016)

Genetic ablation of TAZ induces HepG2 liver cancer cell apoptosis through activating the CaMKII/MIEF1 signaling pathway
por: Hou, Yi, et al.
Publicado: (2019)

Role of Glucose Metabolism Reprogramming in the Pathogenesis of Cholangiocarcinoma
por: Pant, Kishor, et al.
Publicado: (2020)

Reprogramming of glucose metabolism in virus infected cells
por: Goyal, Priya, et al.
Publicado: (2023)

Targeting UDP‐glucose dehydrogenase inhibits ovarian cancer growth and metastasis
por: Lin, Li‐Hsun, et al.
Publicado: (2020)

Metabolic reprogramming of the ovarian cancer microenvironment in the development of antiangiogenic resistance: Metabolic reprogramming of the OC microenvironment
por: Yue, Huiran, et al.
Publicado: (2023)

The potential role of reprogrammed glucose metabolism: an emerging actionable codependent target in thyroid cancer
por: Duan, Sai-li, et al.
Publicado: (2023)

Correction: Cholesterol reprograms glucose and lipid metabolism to promote proliferation in colon cancer cells
por: Mayengbam, Shyamananda Singh, et al.
Publicado: (2023)

Retraction Note: Mst1 overexpression combined with Yap knockdown augments thyroid carcinoma apoptosis via promoting MIEF1-related mitochondrial fission and activating the JNK pathway
por: Zhang, Xiaoli, et al.
Publicado: (2023)

SQLE Mediates Metabolic Reprogramming to Promote LN Metastasis in Castration-Resistant Prostate Cancer
por: Xu, Zhenzhou, et al.
Publicado: (2021)

The Protein Coded by a Short Open Reading Frame, Not by the Annotated Coding Sequence, Is the Main Gene Product of the Dual-Coding Gene MIEF1
por: Delcourt, Vivian, et al.
Publicado: (2018)

The roles of glucose metabolic reprogramming in chemo- and radio-resistance
por: Lin, Jinguan, et al.
Publicado: (2019)

SIX4 upregulates IDH1 and metabolic reprogramming to promote osteosarcoma progression
por: Li, Bing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6jvdkt3jkmpe7bcds87ikv0l8r